BC-LI-0186
Product Specifications
CAS Number
695207-56-8
SKU
C01272-5mg
Target
DNA/RNA Synthesis
Applications
Cell Cycle
Smiles
CC (C) C1=C (C) N (C) N (C1=O) C2=CC=C (C=C2) [S] (=O) (=O) NCCOC3=CC=CC=C3
Additionnal Information
BC-LI-0186 is a selective blocker of Leucyl-tRNA synthetase (LRS, LeuRS) and Ras-related GTP-binding protein D (RagD) interaction (LRS-RagD interaction) (IC50 = 46.11 nM) by competing against RagD for LRS VC domain binding (KD = 42.1 nM), thereby inhibiting lysosomal localization of LRS and mTORC1 activity. It also effectively suppresses the activity of cancer-associated mTOR mutants and the growth of rapamycin-resistant cancer cells.
Storage Conditions
3 years -20°C powder
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BICY1031 1 g
Heptakis (2,3-di-O-acetyl-6-sulfo) -beta-cyclodextrin sodium salt
Sign In for Pricing
View Details 
MBS2075975-01 0.1 mL
APC-Linked Polyclonal Antibody to Wilms Tumor Protein (WT1)
Sign In for Pricing
View Details MBS2075975-02 0.2 mL
APC-Linked Polyclonal Antibody to Wilms Tumor Protein (WT1)
Sign In for Pricing
View Details MBS2075975-03 0.5 mL
APC-Linked Polyclonal Antibody to Wilms Tumor Protein (WT1)
Sign In for Pricing
View Details